Ischemic stroke in cancer: mechanisms, biomarkers, and implications for treatment

G Costamagna, BB Navi, M Beyeler… - … in thrombosis and …, 2023 - thieme-connect.com
Ischemic stroke is an important cause of morbidity and mortality in cancer patients. The
underlying mechanisms linking cancer and stroke are not completely understood. Long …

Diagnosing cancer-associated ischemic stroke: A systematic review of hematological biomarkers

M Erritzøe-Jervild, J Wenstrup… - … Journal of Stroke, 2024 - journals.sagepub.com
Background and aim: Patients suffering from cancer are reported to have an increased risk
of ischemic stroke (IS). We aimed to identify cancer-associated biomarkers found to …

A risk model for prediction of diagnosis of cancer after ischemic stroke

K Seystahl, D Gramatzki, M Wanner, SJ Weber… - Scientific Reports, 2023 - nature.com
It remains controversial which characteristics may predict occult cancer in stroke patients.
Characteristics of patients with ischemic stroke registered in the Zurich Swiss Stroke …

Clinical and demographic characteristics, mechanisms, and outcomes in patients with acute ischemic stroke and newly diagnosed or known active cancer

G Costamagna, A Hottinger, H Milionis, D Lambrou… - Neurology, 2023 - AAN Enterprises
Background and Objectives Patients with a new diagnosis of cancer carry an increased risk
of acute ischemic stroke (AIS), and this risk varies depending on age, cancer type, stage …

Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the …

G Ntaios, H Baumgartner, W Doehner… - European Heart …, 2024 - academic.oup.com
One in six ischaemic stroke patients has an embolic stroke of undetermined source (ESUS),
defined as a stroke with unclear aetiology despite recommended diagnostic evaluation. The …

Absence of susceptibility vessel sign and hyperdense vessel sign in patients with cancer-related stroke

M Beyeler, L Grunder, J Göcmen, F Steinauer… - Frontiers in …, 2023 - frontiersin.org
Background and aim Identification of paraneoplastic hypercoagulability in stroke patients
helps to guide investigations and prevent stroke recurrence. A previous study demonstrated …

Prevalence of right-to-left shunt in stroke patients with cancer

F Steinauer, P Bücke, E Buffle… - … Journal of Stroke, 2024 - journals.sagepub.com
Background and Objectives: Cancer is associated with an increased risk of acute ischemic
stroke (AIS) and venous thromboembolism. The role of a cardiac right-to-left shunt (RLS) as …

Transient ischemic attacks in patients with active and occult cancer

M Beyeler, P Castigliego, J Baumann, V Ziegler… - Frontiers in …, 2023 - frontiersin.org
Background and aim Paraneoplastic coagulopathy can present as stroke and is associated
with specific biomarker changes. Identifying paraneoplastic coagulopathy can help guide …

[HTML][HTML] Mortality in acute ischemic stroke patients with new cancer diagnosed during the index hospitalization versus after discharge

J Göcmen, F Steinauer, M Kielkopf, M Branca… - Journal of Stroke and …, 2024 - Elsevier
Background Early diagnosis of previously unknown cancer (ie, occult cancer) after an acute
ischemic stroke (AIS) could result in faster initiation of cancer therapy and potentially …

[HTML][HTML] Systematic review and meta-analysis of studies comparing baseline D-dimer level in stroke patients with or without cancer: Strength of current evidence

RK Mishra, VK Chavda… - … of Neurosciences in …, 2024 - ncbi.nlm.nih.gov
Objectives: D-dimer levels are increased in stroke and cancer. Cancer patients are at a
higher risk of stroke. However, the evidence is unclear if high D-dimer in stroke patients can …